Ignite Creation Date:
2024-05-06 @ 10:52 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03373708
Status:
UNKNOWN
Last Update Posted:
2017-12-18
First Post:
2017-12-11
Brief Title:
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
Sponsor:
Zhiyong Yu
Organization:
Shandong Cancer Hospital and Institute
Organization Data
Organization:
Shandong Cancer Hospital and Institute
Class:
OTHER
Study ID:
ShandongCHI-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhiyong Yu
Lead Sponsor Class:
OTHER
Responsible Party:
Zhiyong Yu
Responsible Party Title:
Director of the Breast Surgery Ⅰ
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Shandong Cancer Hospital and Institute
Old Name:
None
Old Organization:
None